These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1771 related articles for article (PubMed ID: 27072307)

  • 1. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
    Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty Assessment in Advanced Heart Failure.
    Madan SA; Fida N; Barman P; Sims D; Shin J; Verghese J; Piña I; Jorde U; Patel SR
    J Card Fail; 2016 Oct; 22(10):840-4. PubMed ID: 26883168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.
    Rodríguez-Pascual C; Paredes-Galán E; Ferrero-Martínez AI; Gonzalez-Guerrero JL; Hornillos-Calvo M; Menendez-Colino R; Torres-Torres I; Vilches-Moraga A; Galán MC; Suarez-Garcia F; Olcoz-Chiva MT; Rodríguez-Artalejo F
    Int J Cardiol; 2017 Jun; 236():296-303. PubMed ID: 28215465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence and Prognostic Significance of Frailty in Patients With Advanced Heart Failure Referred for Heart Transplantation.
    Jha SR; Hannu MK; Chang S; Montgomery E; Harkess M; Wilhelm K; Hayward CS; Jabbour A; Spratt PM; Newton P; Davidson PM; Macdonald PS
    Transplantation; 2016 Feb; 100(2):429-36. PubMed ID: 26516676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
    Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
    BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction.
    Pérez-Calvo JI; Morales-Rull JL; Gimeno-Orna JA; Lasierra-Díaz P; Josa-Laorden C; Puente-Lanzarote JJ; Bettencourt P; Pascual-Figal DA
    Am J Cardiol; 2016 Aug; 118(4):543-9. PubMed ID: 27338207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive variables for mortality in elderly patients hospitalized due to heart failure with preserved ejection fraction].
    Carrasco-Sánchez FJ; Páez-Rubio MI; García-Moreno JM; Vázquez-García I; Araujo-Sanabria J; Pujo-de la Llave E
    Med Clin (Barc); 2013 Nov; 141(10):423-9. PubMed ID: 23790575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Value of Objective Frailty Assessment to Predict Mortality in Elderly Patients Hospitalized for Heart Failure.
    Tanaka S; Kamiya K; Hamazaki N; Matsuzawa R; Nozaki K; Maekawa E; Noda C; Yamaoka-Tojo M; Matsunaga A; Masuda T; Ako J
    J Card Fail; 2018 Nov; 24(11):723-732. PubMed ID: 30010026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
    JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frailty, hospitalization, and progression of disability in a cohort of disabled older women.
    Boyd CM; Xue QL; Simpson CF; Guralnik JM; Fried LP
    Am J Med; 2005 Nov; 118(11):1225-31. PubMed ID: 16271906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.
    Vidán MT; Sánchez E; Fernández-Avilés F; Serra-Rexach JA; Ortiz J; Bueno H
    Clin Cardiol; 2014 Dec; 37(12):725-32. PubMed ID: 25516357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
    Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
    Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2021 Aug; 8(4):2876-2888. PubMed ID: 34080791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases.
    Sánchez E; Vidán MT; Serra JA; Fernández-Avilés F; Bueno H
    Heart; 2011 Oct; 97(19):1602-6. PubMed ID: 21795299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.